United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

18 Aug 2017
Change (% chg)

$0.07 (+0.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Smith, Scott 

Mr. Scott A. Smith serves as President, Chief Operating Officer of the Company. Prior thereto he was President, Global Inflammation & Immunology (I & I) since August 2014. Previously he was Senior Vice President, Global Head of I & I. He joined Celgene in 2008 as Vice President, Global Marketing Inflammation and Immunology. From 2003 to 2008, Mr. Smith was with Biovail, holding positions of General Manager Biovail U.S., General Manager Biovail Canada and Global Commercial Head. As Global Commercial Head for Biovail, he was responsible for global revenue generation, global commercial strategies, business development strategy, and input into global regulatory and clinical development strategies. Prior to Biovail, Mr. Smith was with Pharmacia/Upjohn for 16 years where he held various positions including Vice President U.S. Sales, Vice President Marketing Europe based in Paris, Vice President and Commercial Lead for Canada based in Toronto, and Commercial and Regulatory Head for South East Asia based in Hong Kong. Mr. Smith holds a BSc in Chemistry and an HBSc in Pharmacology and Toxicology from the University of Western Ontario and a Masters of International Business Management from the American Graduate School of International Management (Thunderbird). Mr. Smith became a member of the Board of Directors of Titan Pharmaceuticals on January 1, 2017.

Basic Compensation

Total Annual Compensation, USD 1,988,490
Restricted Stock Awards, USD 2,386,840
Long-Term Incentive Plans, USD --
All Other, USD 2,088,460
Fiscal Year Total, USD 6,463,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin


Scott Smith


Mark Alles


Peter Kellogg


Terrie Curran


Michael Pehl

As Of  30 Dec 2016